Ohr Pharmaceutical Announces Pricing of $14.175 Million Public Offering of Common Stock and Warrants
Apr 05, 2017 13:23 pm UTC| Business
NEW YORK, April 05, 2017 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that it has priced a registered public offering at a price to the public of $0.70...
Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares
Apr 05, 2017 13:21 pm UTC| Business
JERSEY, Channel Islands, April 05, 2017 -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of 7,000,000 of its ordinary shares at a...
Gas Turbines Market worth over $20.5 Billion & growing with 4% CAGR by 2021: ZMR
Apr 05, 2017 13:21 pm UTC| Business
Sarasota, FL, April 05, 2017 -- Zion Market Research has published a new report titled “Gas Turbines Market (Heavy Duty and Aeroderivative), By Rated Capacity (1 To 40 MW, 40 To 120 MW, 120 To 300 MW, and Above 300 MW),...
SteadyMed Completes Clinical Validation Study of Trevyent®
Apr 05, 2017 13:03 pm UTC| Business
SAN RAMON, Calif., April 05, 2017 -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral...
Brainsway Closes 2016 With 69 Percent Increase in Year-over-Year Revenue Growth
Apr 05, 2017 13:02 pm UTC| Business
HACKENSACK, N.J., April 05, 2017 -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced today its financial reports for 2016....
Malvern Federal Promotes William J. Boylan to Executive Vice President and Chief Lending Officer
Apr 05, 2017 13:01 pm UTC| Business
PAOLI, Pa., April 05, 2017 -- Malvern Bancorp, Inc., (NASDAQ:MLVF) (the “Company”), parent company of Malvern Federal Savings Bank (“Malvern” or the “Bank”), today announced that it has promoted William J. Boylan to...
Apr 05, 2017 13:01 pm UTC| Business
NEW YORK, April 05, 2017 -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and Chief Executive...